Brief: India's Dr. Lal Pathlabs Sept Quarter Consol Net Profit Rises
08/11/2019 09:14
Nov 8 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS :
* SEPT QUARTER CONSOL NET PROFIT 805 MILLION RUPEES VERSUS
569.
MILLION RUPEES YEAR AGO
* SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 3.66 BILLION
RUPEES
VERSUS 3.18 BILLION RUPEES YEAR AGO
Source text for Eikon: ID:
Further company coverage: DLPA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise